Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-14

Clinical Trial Update: Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effect of 5, 10, or 25 mg daily YF476 for 14 days on stomach acidity in healthy volunteers, sponsored by Trio Medicines Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YF476

Snippet

Sponsor: Trio Medicines Ltd. | Conditions: Reflux Oesophagitis | Phase 1 | Status: COMPLETED